Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review (Q35128730)

6 August 2017

1 reference

title

Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review (English)

1 reference

6 August 2017

0 references

1 reference

Miles R Stanford

1

1 reference

6 August 2017

Sarah E See

series ordinal

2

1 reference

6 August 2017

Leanne V Jones

series ordinal

3

1 reference

6 August 2017

Ruth E Gilbert

series ordinal

4

1 reference

6 August 2017

1 May 2003

1 reference

6 August 2017

1 reference

6 August 2017

110

1 reference

6 August 2017

5

1 reference

6 August 2017

926-31; quiz 931-2

1 reference

Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

1 reference

7 January 2021

Ocular involvement in toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Is ocular toxoplasmosis caused by prenatal or postnatal infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group .

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Results of 20-year follow-up of congenital toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Therapy of ocular toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Current practices in the management of ocular toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Therapy for ocular toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

A comparative study concerning the treatment of active toxoplasmic retinochoroiditis with argon laser and medication (follow-up 2-9 years).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

The treatment of ocular toxoplasmosis with spiramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Treatment of uveitis with pyrimethamine (daraprim)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

TOXOPLASMIC RETINOCHOROIDITIS: A DOUBLE BLIND THERAPEUTIC STUDY

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Evaluation of the Effect of Drugs on the Cyst Form of Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Evaluation of the efficacy of prolonged administration of azithromycin in a murine model of chronic toxoplasmosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Azithromycin for ocular toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Tr

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

A follow-up study of Toxoplasma gondii infection in southern Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

An update on current practices in the management of ocular toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

Acknowledging the importance of study design in the organization and quality of manuscripts

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900083-6

7 January 2021

10.1016/S0161-6420(03)00083-6

Identifiers

DOI

1 reference

6 August 2017

1 reference